Filing Flows › Invo Fertility (IVF) › Q4 2025
Invo Fertility (IVF) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Jun 2, 2026
Invo Fertility (IVF) reported revenue of $1.6M for the fourth quarter 2025 (Q4 2025), -6% from a year earlier and -10% from the quarter before. Operating margin was -89.2%, net earnings $1.1M (69.2% of revenue).
Invo Fertility, Q4 2025: revenue $1.6M (-6% year over year), operating margin -89.2%, net earnings $1.1M, operating cash flow $25K. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.6M | -10% | -6% |
| Operating profit | −$1.4M | — | — |
| Net earnings | $1.1M | — | -76% |
| Operating cash flow | $25K | — | — |
| Free cash flow | $13K | — | — |
What changed
Revenue was $1.6M in Q4 2025, down 6% year over year and down 10% from the previous quarter. Clinic Revenue was the largest line at 98% of revenue.
Operating costs exceeded revenue by $1.4M, an operating margin of -89.2%. Total costs fell 18% while revenue fell 6%. Net earnings were $1.1M. The effective tax rate was 41.1%. Non-operating items added $3.3M, 176% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was $25K, 2% of net earnings. Non-cash charges added back $136K of depreciation and amortization. Working capital and other items used $1.2M. Capital expenditures of $12K left free cash flow of $13K.
Questions
What was Invo Fertility's revenue in the fourth quarter 2025?
Invo Fertility (IVF) reported revenue of $1.6M for the fourth quarter 2025 (Q4 2025), -6% from a year earlier and -10% from the quarter before.
Was Invo Fertility profitable in the fourth quarter 2025?
Operating loss was $1.4M (-89.2% of revenue) and net earnings $1.1M.
Source: Invo Fertility 10-K on SEC EDGAR.